Monsanto is partnering with Massachusetts Institute of Technology researchers to form a company that will focus on developing technologies to create new biological products for pest, virus and weed control.
The partnership will use research that MIT has been developing for medicine and apply it to agriculture. The firm, Preceres LLC, will be based in Cambridge, Mass. It aims to discover and develop new materials and methods for the delivery of ribonucleic acid into targeted plants and insects, according to the new firm’s website.
Creve Coeur-based Monsanto said its investment in Preceres is part of its corporate venture group, Monsanto Growth Ventures.